Cocrystal Pharma Files 8-K
Ticker: COCP · Form: 8-K · Filed: Sep 12, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 8-K |
| Filed Date | Sep 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: CCPH
TL;DR
CCPH filed a routine 8-K, no major news.
AI Summary
Cocrystal Pharma, Inc. filed an 8-K on September 12, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Cocrystal Pharma, Inc. is meeting its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory compliance and does not disclose any new material information or risks.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Registrant
- September 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38418 (filing_id) — Commission File Number
- 35-2528215 (tax_id) — IRS Employer Identification No.
- 19805 N. Creek Parkway Bothell, WA 98011 (address) — Principal executive offices
- (877) 262-7123 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits, as indicated in the filing details.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is September 12, 2025.
In which U.S. state is Cocrystal Pharma, Inc. incorporated?
Cocrystal Pharma, Inc. is incorporated in Delaware.
What is the Commission File Number for Cocrystal Pharma, Inc.?
The Commission File Number for Cocrystal Pharma, Inc. is 001-38418.
What is the business address of Cocrystal Pharma, Inc.?
The business address of Cocrystal Pharma, Inc. is 19805 N. Creek Parkway, Bothell, WA 98011.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-09-12 17:30:19
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 7KB
- 0001641172-25-027246.txt ( ) — 224KB
- cocp-20250912.xsd (EX-101.SCH) — 3KB
- cocp-20250912_lab.xml (EX-101.LAB) — 33KB
- cocp-20250912_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cocrystal Pharma, Inc. Date: September 12, 2025 By: /s/ James Martin Name: James Martin Title: Chief Financial Officer and Co-Chief Executive Officer